7,8-Dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione
- CAS
- 39713-40-1
- Formula
- C10H9NO2
- MW
- 175.18 g/mol
ZX-035237
Application
Chemicals for pharmaceutical manufacturing and QC
Building blocks, intermediates, APIs, impurity standards and chromatography solvents for drug developers, formulators and release laboratories.
Products used in pharmaceutical manufacturing and QC
12,721–12,744 of 35,907 products
7,8-Dimethoxy-3-(3-(methylamino)propyl)-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one Hydrochloride
- CAS
- 85175-52-6
- Formula
- C16H25ClN2O3
- MW
- 328.83 g/mol
ZX-025206
7,9-di-tert-butyl-1-oxaspiro[4.5]deca-6,9-diene-2,8-dione
- CAS
- 82304-66-3
- Formula
- C17H24O3
- MW
- 276.4 g/mol
ZX-007759
7,9-Dioxo-8-azaspiro[4.5]decane-6,10-dicarbonitrile
- CAS
- 42940-56-7
- Formula
- C11H11N3O2
- MW
- 217.22 g/mol
ZX-028384
8 3 Aminopiperidin 1 yl 7 but 2 yn 1 yl 3 methyl 1 4 methylquinazolin 2 yl Methyl 3 7 dihydro 1h purine 2 6 dione
- CAS
- 1383917-84-7
- Formula
- C25H28N8O2
- MW
- 472.5 g/mol
ZX-030292
8-((2-Chlorophenyl)sulfonyl)-2-((4-methyl-1-piperazinyl)methyl)-1-oxa-8-azaspiro(4.5)decane
- CAS
- 2096376-12-2
- Formula
- C20H30ClN3O3S
- MW
- 427.99 g/mol
ZX-041998
8-((3R,4S)-4-Ethyl-1-((2,2,2-trifluoroethyl)carbamoyl)pyrrolidin-3-yl)-N-(2,2,2-trifluoroethyl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine-3-carboxamide
- CAS
- 2715120-86-6
- Formula
- C20H21F6N7O2
- MW
- 505.4 g/mol
ZX-027468
8-((3R,4S)-4-Ethylpyrrolidin-3-yl)-3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine
- CAS
- 1428243-28-0
- Formula
- C21H23N5O2S
- MW
- 409.5 g/mol
ZX-027471
8-((3R,4S)-4-Ethylpyrrolidin-3-yl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine
- CAS
- 1708997-43-6
- Formula
- C14H17N5
- MW
- 255.32 g/mol
ZX-027470
8-(2-(4-Chlorophenyl)acetyl)-3-(phenylmethyl)-1,3,8-triazaspiro(4.5)decane-2,4-dione
- CAS
- 1574602-46-2
- Formula
- C22H22ClN3O3
- MW
- 411.88 g/mol
ZX-042007
Questions
Buying for pharmaceutical manufacturing and QC
Can I buy an API and its pharmacopoeial impurities in one enquiry?
Yes. Add the API and the named impurities to the quote panel together. We confirm which impurity standards are available from stock, which need synthesis and what characterisation data comes with each, so your method validation and supply qualification can run in parallel.
Are excipients available alongside the active ingredient?
Common excipients such as microcrystalline cellulose, lactose monohydrate, povidone and magnesium stearate can be quoted with pharmacopoeial documentation where the producer supplies it. State the monograph and edition you work to, and the COA will report against it.
How do you handle solvents that are controlled precursors?
Some solvents and reagents used in drug synthesis are listed precursors in India or at destination. We flag these on the quotation and may ask for an end-use declaration or import permit before dispatch. Sharing your licence details early avoids delays.
Other applications
Agrochemicals and Crop ProtectionWater and Wastewater TreatmentPaints, Coatings and InksTextiles, Dyes and LeatherFood, Beverage and NutritionCosmetics and Personal CareElectronics, PCB and SemiconductorsResearch Labs and UniversitiesOil, Gas and PetrochemicalsPolymers, Plastics and RubberBatteries and Energy StorageMining, Mineral Processing and MetallurgyDiagnostics, Life Science and Biotech